Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization
about
The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro.Novel reduction-sensitive micellar nanoparticles assembled from Rituximab-doxorubicin conjugates as smart and intuitive drug delivery systems for the treatment of non-Hodgkin's lymphoma.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.Trial Watch: Immunostimulation with recombinant cytokines for cancer therapyMicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells
P2860
Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combating rituximab resistance ...... of CD20-TNFR1 co-localization
@en
Combating rituximab resistance ...... of CD20-TNFR1 co-localization.
@nl
type
label
Combating rituximab resistance ...... of CD20-TNFR1 co-localization
@en
Combating rituximab resistance ...... of CD20-TNFR1 co-localization.
@nl
prefLabel
Combating rituximab resistance ...... of CD20-TNFR1 co-localization
@en
Combating rituximab resistance ...... of CD20-TNFR1 co-localization.
@nl
P2093
P2860
P1433
P1476
Combating rituximab resistance ...... of CD20-TNFR1 co-localization
@en
P2093
Biqin Dong
Honghong Zhang
Jingkun Pan
Junlan Yang
P2860
P304
P356
10.1080/2162402X.2016.1143995
P577
2016-02-18T00:00:00Z